Fabio Corsi

Responsabile di servizio, Dirigente medico

Towards Ideal Magnetofluorescent Nanoparticles for Bimodal Detection of Breast-Cancer Cells. Corsi F, De Palma C, Colombo M, Allevi R, Nebuloni M, Ronchi S, Rizzi G, Tosoni A, Trabucchi E, Clementi E, Prosperi D. Small. 2009 Nov;5(22):2555-64. I.F. 7.336

Usefulness of preoperative diagnosis with magnetic resonance imaging for conservative surgery in Paget’s disease of the breast Corsi.F., Sartani A., Galli D., Alineri S., Uccelli M., Fontana a., Foschi D.Breast Care 2010; 5:26-28 I.F.: 0.364

HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice.Corsi F, Fiandra L, De Palma C, Colombo M, Mazzucchelli S, Verderio P, Allevi R, Tosoni A, Nebuloni M, Clementi E, Prosperi D. ACS Nano. 2011 Aug 1, 5 (8):6383-6393, I.F. 11.421

Assessing the In Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands. Fiandra L, Mazzucchelli S, De Palma C, Colombo M, Allevi R, Sommaruga S, Clementi E, Bellini M, Prosperi D, Corsi F ACS Nano, 2013, 7 (7), pp 6092–6102 -DOI: 10.1021/nn4018922 Publication Date (Web): June 4, 2013 -I.F.  12.033

Localization of nonpalpable breast lesions with sonographically visible clip: optimizing tailored resection and clear margins. Corsi F, Sorrentino L, Sartani A, Bossi D, Amadori R, Nebuloni M, Truffi M, Bonzini M, Foschi D. Am J Surg. 2014 Oct 12. pii: S0002-9610(14)00506-6. doi: 10.1016/j.amjsurg. 2014.07.010 [Epub ahead of print] PMID: 25457243 – I.F. 2.291

Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice. Fiandra L, Colombo M, Mazzucchelli S, Truffi M, Santini B, Allevi R, Nebuloni M, Capetti A, Rizzardini G, Prosperi D, Corsi F. Nanomedicine: Nanotechnology, Biology and Medicine 11 (2015) 1387-1397 doi: 10.1016/j.nano. 2015.03. 009.– I.F. 5.671

A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project La Verde N, Corsi F, Moretti A, Peissel B, Dalu D, Girelli S, Fasola C, Gambaro A, Roversi G, Azzolini J, Radice P, Pensotti V, Farina G, Manoukian S.Tumori, 2015 Sep 10; doi:10.5301/tj.5000407 (epub ahead of print) –I.F 1.071

New perspectives on nanotechnology and antiretroviral drugs: a small solution for a big promise in HIV treatment? Corsi F, Fiandra L, Rizzardini G. AIDS 2016, 30:963-964 DOI: 10.1097/QAD.0000000000001026- I.F. 4.064

Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies Colombo M, Fiandra L, Alessio G, Mazzucchelli S, Nebuloni M, De Palma C, Kantner K, Pelaz B, Rotem R, Corsi F, Parak WJ, Prosperi D, Nature Communications 7:13818 (2016) | DOI: 10.1038/ncomms13818 IF 11.329

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity Mazzucchelli S, Bellini M, Fiandra L, TruffiM, Rizzuto M, Sorrentino L, Longhi L, Nebuloni M; Prosperi D, Corsi F Oncotarget. 2016 Dec 25. doi: 10.18632/oncotarget.14204. [Epub ahead of print] IF: 10.452